Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Murine anti-CD22 antibody variable region fused to truncated Pseudomonas exotoxin 38

EU orphan designation number: EU/3/08/592   
Active ingredient: Murine anti-CD22 antibody variable region fused to truncated Pseudomonas exotoxin 38
Indication: Treatment of hairy cell leukaemia
Sponsor: AstraZeneca AB
151 85 Södertälje, Sverige

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
9/12/2008 Orphan designation EMEA/OD/066/08 (2008)8168 of 4/12/2008
16/01/2019 Transfer of orphan designation EMA/OD/0000002546 (2019)231 of 11/01/2019